Anzeige
Mehr »
Login
Donnerstag, 23.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Amazon investiert Millionen in Kernenergie - so können Sie sich früh positionieren!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
510 Leser
Artikel bewerten:
(2)

Axiom Space: Ax-3 Astronauts Splashdown, Completing First All-European Commercial Astronaut Mission to ISS

Finanznachrichten News

HOUSTON, Feb. 9, 2024 /PRNewswire/ -- After undocking from the International Space Station (ISS) on Wednesday, Feb. 7, the Axiom Mission 3 (Ax-3) crew safely splashed down off the coast of Florida aboard a SpaceX Dragon spacecraft at 8:30 a.m. ET on Feb. 9, 2024. The Ax-3 crew's return officially concludes the first all-European commercial astronaut mission and Axiom Space's third crewed mission to the ISS.

The Axiom Mission 3 (Ax-3) crewmembers, Commander Michael López-Alegría of the U.S. and Spain, Pilot Walter Villadei of Italy, and Mission Specialists Alper Gezeravci of Türkiye and European Space Agency (ESA) Project Astronaut Marcus Wandt of Sweden, float in microgravity during their mission to the International Space Station with Axiom Space.

The Ax-3 crewmembers include Commander Michael López-Alegría of the U.S. and Spain, Pilot Walter Villadei of the Italian Air Force, and Mission Specialists Alper Gezeravci of Türkiye and Marcus Wandt of Sweden and the European Space Agency (ESA).

"The successful return of our Ax-3 astronauts signifies more than just the completion of a human spaceflight mission; it marks a pivotal moment in commercial space exploration and significant milestone for Europe's pursuits in low-Earth orbit," said Axiom Space CEO Michael Suffredini. "Axiom Space's first three commercial missions to the ISS are a testament to international advancement in space, with diverse crews representing eight nations, as well as - for the first time on Ax-3 - the European Space Agency. The success of these missions is an important step along our journey toward Axiom Station, underscoring our continuous efforts to expand access to low-Earth orbit."

During their 18-day mission docked to the ISS, the Ax-3 crew lived and worked aboard the orbiting laboratory conducting more than 30 different experiments and more than 50 outreach engagements. Human research data collected on the ground before and after the mission, as well as in flight, will improve understanding of human physiology on Earth and in microgravity.

Ax-3 demonstrates that the European community of space-faring nations are pioneers in the burgeoning commercial space industry. The crew and the governments they represent are taking bold steps into a new era of leadership in low-Earth orbit.

Ax-3 celebrates many firsts: it was the first commercial spaceflight mission comprised of government and ESA-sponsored national astronauts; Mission Specialist Alper Gezeravci became the first-ever Turkish astronaut; and Mission Specialist Marcus Wandt was the first ESA project astronaut to fly on a commercial space mission.

Ax-3 is the third in a series of proposed Axiom Space human spaceflight missions, marking a critical milestone toward the realization of Axiom Station - the world's first commercial space station.

Axiom Space is playing an important role in offering human spaceflight opportunities to the larger international community. These missions are enabling governments, individuals, researchers, academic institutions, and organizations across the world to conduct comprehensive scientific research, technology demonstrations, and outreach engagements in the unique environment of microgravity.

Axiom Space's first three missions to the ISS included crewmembers from the U.S., Spain, Israel, Canada, Saudi Arabia, Italy, Türkiye, and Sweden, with the support of ESA. In addition, last year, Axiom Space signed an MOU with ESA and the UK Space Agency to explore future human spaceflight opportunities.

Axiom Space plans to launch its fourth mission, Axiom Mission 4 (Ax-4), to the ISS no earlier than October 2024 from NASA's Kennedy Space Center in Florida.

Watch the replay of the splashdown at www.axiomspace.com.

ABOUT AXIOM SPACE

Axiom Space is building for beyond, guided by the vision of a thriving home in space that benefits every human, everywhere. The leading provider of human spaceflight services and developer of human-rated space infrastructure, Axiom Space operates end-to-end missions to the International Space Station today while developing its successor, Axiom Station - the world's first commercial space station in low-Earth orbit, which will sustain human growth off the planet and bring untold benefits back home. www.axiomspace.com.

Contact:
media@axiomspace.com

Photo - https://mma.prnewswire.com/media/2337907/Ax3_CrewISS_Axiom_Space.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/ax-3-astronauts-splashdown-completing-first-all-european-commercial-astronaut-mission-to-iss-302058633.html

© 2024 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.